Indivior PLC (LON:INDV – Get Free Report) shares passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 805.29 ($10.39) and traded as low as GBX 714 ($9.21). Indivior shares last traded at GBX 733 ($9.46), with a volume of 401,184 shares.
Analyst Upgrades and Downgrades
Separately, Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 1,800 ($23.22) target price on shares of Indivior in a report on Tuesday, December 17th.
Check Out Our Latest Analysis on INDV
Indivior Stock Performance
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Further Reading
- Five stocks we like better than Indivior
- What Are Some of the Best Large-Cap Stocks to Buy?
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Investing in Commodities: What Are They? How to Invest in Them
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.